Quick Summary
Immunotherapy for colorectal cancer boosts the immune system to target and kill cancer cells. It's most effective for advanced or metastatic cancer with microsatellite instability high (MSI-H) or mismatch repair deficiency (dMMR). This treatment works by blocking proteins that prevent immune cells from attacking the cancer.
|
What is Immunotherapy for Colorectal Cancer?
Immunotherapy is a treatment that helps the body’s immune system fight cancer. For colorectal cancer, this treatment can be very effective, especially when other treatments don’t work. It uses special drugs to boost the immune system and help it target and destroy cancer cells. This treatment is mostly used for advanced cancer or cancer that has spread to other parts of the body.
Immunotherapy works by blocking certain proteins that prevent immune cells from attacking cancer cells. It is mainly used in patients with a type of colorectal cancer called microsatellite instability high (MSI-H) or mismatch repair deficiency (dMMR). These conditions make it easier for the immune system to recognize and fight cancer cells.
Who is Eligible for Immunotherapy in Colorectal Cancer Treatment?
Not everyone with colorectal cancer is a candidate for immunotherapy. To determine eligibility, doctors consider several factors, including the genetic makeup of the cancer. Some of the main factors for eligibility include:
Microsatellite Instability (MSI-H) or Mismatch Repair Deficiency (dMMR)
Tumors with MSI-H or dMMR are more likely to respond to immunotherapy. These conditions cause the tumor cells to have more mutations, making them easier for the immune system to identify and destroy. Your oncologist will run a tumor profiling test on the cancer specimen to determine the actionable mutation genes to find out the corresponding effective immunotherap drugs.
Advanced Cancer Stages
Immunotherapy is commonly used for patients with advanced colon cancer or metastatic cancer, which means the cancer has spread beyond the colon to other parts of the body. If other treatments like chemotherapy have not worked, immunotherapy may be an option.
Types of Immunotherapy for Colorectal Cancer
There are different types of immunotherapy used to treat colorectal cancer:
Immune Checkpoint Inhibitors (PD-1 inhibitors)
- PD-1 inhibitors are a type of immunotherapy that blocks the PD-1 protein on immune cells. This allows the immune system to better recognize and attack cancer cells. These drugs are especially effective for cancers with MSI-H or dMMR.
Targeted Therapy with Immunotherapy
- Sometimes, doctors use a combination of immunotherapy and targeted therapy. Targeted therapy focuses on specific molecules involved in cancer growth. When combined with immunotherapy, this can increase the effectiveness of treatment.
| Type of Immunotherapy | How It Works | Best Suited For |
|---|---|---|
| Immune Checkpoint Inhibitors (PD-1 Inhibitors) | Blocks the PD-1 protein on immune cells, helping the immune system recognize and attack colorectal cancer cells more effectively. | Patients with MSI-H or dMMR colorectal cancers. |
| Targeted Therapy Combined with Immunotherapy | Uses drugs that target specific cancer growth molecules alongside immunotherapy to enhance overall treatment effectiveness. | Selected patients where combination treatment improves response compared to immunotherapy alone. |
Side Effects of Immunotherapy for Colorectal Cancer
Like all treatments, immunotherapy has side effects. The most common ones include:
Fatigue
- Many patients feel very tired during treatment. This is one of the most common side effects of immunotherapy.
Skin Problems
- Some people may develop rashes or dry skin during treatment.
Digestive Issues
- In some cases, immunotherapy can cause diarrhea or other gastrointestinal problems.
Autoimmune Reactions
- Immunotherapy works by boosting the immune system, but it can sometimes cause the immune system to attack healthy cells. This can lead to inflammation in various parts of the body.
Is Immunotherapy Right for You?
Immunotherapy is not suitable for all patients with colorectal cancer. It is most effective in patients with MSI-H, dMMR and other proven mutated genes, especially those with advanced cancer. If you have advanced colon cancer or have not responded to other treatments, you might be eligible for this treatment. Your doctor will help decide if immunotherapy is right for you based on your specific situation, including the genetic makeup of your cancer and your health history.
Frequently Asked Questions
Who is eligible for immunotherapy for colon cancer?
Patients with microsatellite instability high (MSI-H), mismatch repair deficiency (dMMR) and other proven actionable mutations are the best candidates for immunotherapy. These genetic conditions make cancer cells more likely to mutate. This helps the immune system find and attack them. Typically, patients with advanced colorectal cancer or metastatic cancer—where the cancer has spread to other parts of the body—are also considered for immunotherapy, especially if conventional treatments have not worked.
How does immunotherapy work for colorectal cancer?
Immunotherapy works by enhancing the body’s immune system to fight off cancer cells. In colon cancer, specific types of immunotherapy, like immune checkpoint inhibitors, help block the proteins that prevent immune cells from attacking cancer. This allows the immune system to recognize cancer cells as foreign invaders and destroy them. Immunotherapy is particularly effective in cancers with MSI-H or dMMR because these tumors have more genetic changes, making them more visible to immune cells.
What are the side effects of immunotherapy for colorectal cancer?
While immunotherapy can be an effective treatment, it does come with potential side effects. Common side effects include fatigue, which can range from mild to severe, skin rashes, and gastrointestinal problems, such as diarrhea or nausea. Immunotherapy can also trigger autoimmune reactions, where the immune system starts attacking healthy tissues, causing inflammation in various parts of the body, including the lungs, intestines, and liver. Your doctor will monitor these side effects closely to manage them and ensure that they do not become severe.
How long does it take to see results from immunotherapy for colon cancer?
Immunotherapy results vary; some patients see improvements in months, while others may take longer. Oncologists monitor progress through regular tests.
